Apps

openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

News

Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

© OpenServe Holdings LLC

Privacy Notice Data rights Terms of Service Feedback Cookie NoticeHelp Acceptable Use Copyright AI Notice Your Privacy Choices Subprocessors Data Processing Addendum Installed App Terms Company Solutions Free assessment Investors Get the app Contact

IJR News — today's news from every side

FDA approves Alzheimer's blood test for age 40+ — Aug 24, 2026The FDA has cleared several Alzheimer’s blood tests, including PrecivityAD2 for adults 40 and older to aid diagnosis in symptomatic cognitive decline (not a general screening tool), and Elecsys pTau217 tests for those 55 and older to detect amyloid pathology and rule in or out Alzheimer's in various care settings, expanding access through Roche’s installed lab network and major providers. These tests, developed by Roche with Lilly and by other providers, aim to simplify early diagnosis and broaden eligibility for related treatments and care pathways.